Apogee Therapeutics Overview
Apogee Therapeutics Target Price
Analysts' 12-month price predictions for APGE.
Get informed when a big investor buys or sells
+ FollowShare Price
$132.88
Average Target Price
$104.17
21.6% downside
21.6% downside6 analysts in the last 4 months
High: $140 | Low: $81
Analyst Recommendations
No recommendations in the last 4 months.
Revenue & Income Forecast
Analysts' Target Prices
| Date | Analyst | Price Target | Current Upside/Downside | |
|---|---|---|---|---|
| 2026-06-08 | RBC CapitalBrian Abrahams | $97 | 27% downside |  |
| 2026-05-28 | Goldman Sachs | $89 | 33% downside | |
| 2026-05-27 | Truist FinancialDanielle Brill | $81 | 39% downside | |
| 2026-05-27 | Wedbush | $135 |  1.6% upside | |
| 2026-05-01 | Redburn PartnersQize Ding | $140 | 5.4% upside | |
| 2026-03-17 | Truist FinancialDanielle Brill | $83 | 37.5% downside | |
| 2026-02-02 | JefferiesAkash Tewari | $95 | 28.5% downside | |
| 2026-01-22 | RBC Capital | $83 | 37.5% downside | |
| 2026-01-07 | Craig-Hallum | $116 | 12.7% downside | |
| 2026-01-06 | BTIG | $137 | 3.1% upside | |
| 2026-01-06 | Stifel Nicolaus | $133 | 0.1% upside | |
| 2025-12-16 | Stephens | $95 | 28.5% downside | |
| 2025-12-09 | Deutsche Bank | $103 | 22.5% downside | |
| 2025-11-03 | Craig-Hallum | $109 | 18% downside | |
| 2025-09-25 | RBC Capital | $60 | 54.8% downside | |
| 2024-05-13 | Stifel NicolausAlex Thompson | $95 | 28.5% downside | |